Financing - April 4, 2019
Gesynta Pharma secures EUR 6 million for development programs
The company has completed a financing round to provide funds for early clinical development of its lead candidate, GS-248. A consortium consisting of venture capital investor Industrifonden and a group of private life sciences investors provides financial and strategic support to Gesynta’s development programs and brings the company to its next pivotal milestone, to make […]
Business article - January 19, 2018
A very strong year for life science funding in Scandinavia
A new report from Industrifonden shows that life science companies in Scandinavia raised $2.2bn in 2017, doubling from 2016 and equivalent to the total funding amount for 2014-2016 ($2.4bn), with strong growth across IPOs, refunds and venture funding. The new report also states that biotech/pharma raised a total of $500m through IPOs, equivalent to 12% of the […]
Funding - November 28, 2016
New Scandinavian life science funding report
A new report from the venture capital investor Industrifonden shows a great interest for life science companies in Scandinavia, with a total investment of $2.4bn from 2014 to the third quarter of 2016. The report is an analysis of the investment landscape and financing activities in the sector in Scandinavia, mapping investment activities of 149 […]
Career choice - December 17, 2013
Investment Manager
Hedvig Andersén talks about her job as an Investment Manager at Industrifonden.
